Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia

NCT01319981 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Rituximab
DRUG: Imatinib
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Mesna
DRUG: VSLI
DRUG: Solu-Medrol
DRUG: Methotrexate
DRUG: Ara-C
DRUG: G-CSF
DRUG: Pegfilgrastim
DRUG: Dexamethasone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]